This randomized phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that have spread to other places in the body (advanced). Cabozantinib is a chemotherapy drug known as a t...
- Neoplasms
- Neuroendocrine Tumors
- Carcinoid Tumor
- Adenoma, Islet Cell
- Intestinal Neoplasms
- Pancreatic Neoplasms
- Stomach Neoplasms
Age: 18 years - 66+
Gender: All